SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 1st, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 25, 2017, is between CANTABIO PHARMACEUTICALS INC., a company incorporated under the laws of the State of Delaware, with headquarters located at 1250 Oakmead Pkwy, Sunnyvale, California, 94085 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 1st, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 25, 2017, by and among CANTABIO PHARMACEUTICALS INC., a Delaware corporation (the “Company”), and YA II PN, Ltd., a Cayman Islands exempt limited partnership (the “Investor”).
SECURITY AGREEMENT (in favor of YA II PN, Ltd.)Security Agreement • February 1st, 2017 • Cantabio Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SECURITY AGREEMENT (the “Agreement”) is entered into as of January 25, 2017 by and among (i) Cantabio Pharmaceuticals Inc., a Delaware corporation (the “Issuer”), and (ii) any subsidiary and affiliate of the Issuer listed on Schedule 1 attached hereto either now or joined in the future (the “Subsidiaries”; and jointly, severally, and collectively with the Issuer, the “Grantors”) in favor of YA II PN, Ltd., a Cayman Islands company (the “Secured Party”).
